Cancer Immunology, Immunotherapy

DC-based vaccine loaded with acid-eluted peptides in acute myeloid leukemia: the importance of choosing the best elution method
pp. 1-12(12)
Authors: Delluc, Stéphanie; Tourneur, Léa; Fradelizi, Didier; Rubio, Marie-Thérèse; Marchiol-Fournigault, Carmen; Chiocchia, Gilles; Buzyn, Agnès

Effects of interferon gamma on native human acute myelogenous leukaemia cells
pp. 13-24(12)
Authors: Ersvaer, Elisabeth; Skavland, Jørn; Ulvestad, Elling; Gjertsen, Bjørn; Bruserud, Øystein

Co-expression of α(1,3)galactosyltransferase and Bacillus thuringiensis PIPLC enhances hyperacute rejection of tumor cells
pp. 25-34(10)
Authors: Hellrung, Daniel; Kisselev, Serguei; Link, Charles

Treatment with HPMA copolymer-based doxorubicin conjugate containing human immunoglobulin induces long-lasting systemic anti-tumour immunity in mice
pp. 35-47(13)
Authors: Sirova, Milada; Strohalm, Jiri; Subr, Vladimir; Plocova, Daniela; Rossmann, Pavel; Mrkvan, Tomas; Ulbrich, Karel; Rihova, Blanka

Tumor-derived CD4⁺CD25⁺ regulatory T cell suppression of dendritic cell function involves TGF-β and IL-10
pp. 48-59(12)
Authors: Larmonier, Nicolas; Marron, Marilyn; Zeng, Yi; Cantrell, Jessica; Romanoski, Angela; Sepassi, Marjan; Thompson, Sylvia; Chen, Xinchun; Andreansky, Samita; Katsanis, Emmanuel

Complement insufficiency limits efficacy in a xenograft model of hyperacute rejection for cancer therapy
pp. 60-69(10)
Authors: Larkin, James; Porter, Colin

The role of CD4+ T cell help in cancer immunity and the formulation of novel cancer vaccines
pp. 70-80(11)
Authors: Assudani, Deepak; Horton, Roger; Mathieu, Morgan; McArdle, Stephanie; Rees, Robert

Tumor escape mechanisms in prostate cancer
pp. 81-87(7)
Authors: Miller, Ashley; Pisa, Pavel

Identification of different tumor escape mechanisms in several metastases from a melanoma patient undergoing immunotherapy
pp. 88-94(7)
Authors: Méndez, Rosa; Ruiz-Cabello, Francisco; Rodríguez, Teresa; Campo, Ana; Paschen, Annette; Schadendorf, Dirk; Garrido, Federico

Impact of KIR/HLA ligand combinations on immune responses in malignant melanoma
pp. 95-100(6)
Authors: Naumova, Elissaveta; Mihaylova, Anastassia; Ivanova, Milena; Mihailova, Snejina

Lymphocyte activation in response to melanoma: interaction of NK-associated receptors and their ligands
pp. 101-109(9)
Authors: Solana, Rafael; Casado, Javier; Delgado, Elena; DelaRosa, Olga; Marín, Juan; Durán, Esther; Pawelec, Graham; Tarazona, Raquel

Recoverin as a cancer-retina antigen
pp. 110-116(7)
Authors: Bazhin, Alexandr; Schadendorf, Dirk; Philippov, Pavel; Eichmüller, Stefan

Immunotherapy of renal cell carcinoma
pp. 117-128(12)
Authors: Gouttefangeas, Cécile; Stenzl, Arnulf; Stevanović, Stefan; Rammensee, Hans-Georg